OP Asset Management Ltd Takes $12.45 Million Position in Danaher Corporation $DHR

OP Asset Management Ltd acquired a new position in shares of Danaher Corporation (NYSE:DHR) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 65,687 shares of the conglomerate’s stock, valued at approximately $12,454,000.

A number of other institutional investors have also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter worth $26,000. WFA of San Diego LLC purchased a new position in shares of Danaher in the 2nd quarter worth $26,000. Hilton Head Capital Partners LLC acquired a new position in Danaher in the fourth quarter valued at $27,000. Finally, Clal Insurance Enterprises Holdings Ltd grew its position in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 53 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Price Performance

Shares of DHR stock opened at $188.78 on Thursday. The firm has a fifty day moving average of $178.97 and a two-hundred day moving average of $201.96. The firm has a market cap of $133.61 billion, a P/E ratio of 36.51, a P/E/G ratio of 2.28 and a beta of 0.81. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.88 earnings per share. As a group, research analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Wells Fargo & Company cut their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 22nd. HSBC decreased their target price on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. UBS Group dropped their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Barclays cut their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Finally, Piper Sandler initiated coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.